Real-World Treatment Study of Koselugo (Selumetinib)

Conditions: Neurofibromatosis 1; Neurofibroma, Plexiform Sponsors: AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials